192 related articles for article (PubMed ID: 32418182)
1. An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research.
Campbell AD; Colombatti R; Andemariam B; Strunk C; Tartaglione I; Piccone CM; Manwani D; Asare EV; Boruchov D; Farooq F; Urbonya R; Boatemaa GD; Perrotta S; Sainati L; Rivers A; Rao S; Zempsky W; Sey F; Segbefia C; Inusa B; Antwi-Boasiako C
J Racial Ethn Health Disparities; 2021 Feb; 8(1):99-106. PubMed ID: 32418182
[TBL] [Abstract][Full Text] [Related]
2. Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana.
Zempsky WT; Yanaros M; Sayeem M; Boruchov D; Piccone CM; Manwani D; Strunk C; Tartaglione I; Colombatti R; Akatue S; Oteng B; Owda A; Bamfo R; Wilson S; Rivers A; Farooq F; Urbonya R; Boatemaa GD; Rao S; Inusa B; Antwi-Boasiako C; Segbefia C; Sey F; Andemariam B; Asare EV; Campbell AD
Pain Med; 2022 Aug; 23(8):1379-1386. PubMed ID: 35166851
[TBL] [Abstract][Full Text] [Related]
3. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.
Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Strunk C; Piccone CM; Manwani D; Boruchov D; Farooq F; Urbonya R; Wilson S; Boatemaa GD; Perrotta S; Sainati L; Rivers A; Rao S; Zempsky W; Ekem I; Sey F; Segbefia C; Inusa B; Tartaglione I; Campbell AD
Ann Hematol; 2020 Sep; 99(9):2073-2079. PubMed ID: 32377816
[TBL] [Abstract][Full Text] [Related]
4. Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort.
Strunk C; Tartaglione I; Piccone CM; Colombatti R; Andemariam B; Manwani D; Smith A; Haile H; Kim E; Wilson S; Asare EV; Rivers A; Farooq F; Urbonya R; Boruchov D; Boatemaa GD; Perrotta S; Ekem I; Sainati L; Rao S; Zempsky W; Sey F; Antwi-Boasiako C; Segbefia C; Inusa B; Campbell AD
Blood Cells Mol Dis; 2021 Dec; 92():102612. PubMed ID: 34564050
[TBL] [Abstract][Full Text] [Related]
5. Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
Tartaglione I; Strunk C; Antwi-Boasiako C; Andemariam B; Colombatti R; Asare EV; Piccone CM; Manwani D; Boruchov D; Tavernier F; Farooq F; Akatue S; Oteng B; Urbonya R; Wilson S; Owda A; Bamfo R; Boatemaa GD; Rao S; Zempsky W; Sey F; Inusa BP; Perrotta S; Segbefia C; Campbell AD
Blood Cells Mol Dis; 2021 May; 88():102531. PubMed ID: 33401140
[TBL] [Abstract][Full Text] [Related]
6. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
Fong C; Menzel S; Lizarralde MA; Barreto G
Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
[TBL] [Abstract][Full Text] [Related]
9. "A complex interface: Exploring sickle cell disease from a parent's perspective, after moving from Sub-Saharan Africa to North America".
Aiko Bruce A; Witol A; Alvadj-Korenic T; Mayan M; Greenslade H; Plaha M; Venner MA
Pediatr Hematol Oncol; 2018; 35(7-8):373-384. PubMed ID: 30785354
[TBL] [Abstract][Full Text] [Related]
10. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.
Mehta KM; Yaffe K; Pérez-Stable EJ; Stewart A; Barnes D; Kurland BF; Miller BL
Neurology; 2008 Apr; 70(14):1163-70. PubMed ID: 18003939
[TBL] [Abstract][Full Text] [Related]
11. Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?
Bitoungui VJ; Pule GD; Hanchard N; Ngogang J; Wonkam A
OMICS; 2015 Mar; 19(3):171-9. PubMed ID: 25748438
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory features of sickle cell disease in The Netherlands.
Aluoch JR; De Geus A; Goudsmit R
Trop Geogr Med; 1988 Jan; 40(1):7-12. PubMed ID: 3381319
[TBL] [Abstract][Full Text] [Related]
13. Living with sickle cell disease: traversing 'race' and identity.
Royal CD; Jonassaint CR; Jonassaint JC; De Castro LM
Ethn Health; 2011; 16(4-5):389-404. PubMed ID: 21797725
[TBL] [Abstract][Full Text] [Related]
14. Caring for Africa's sickle cell children: will we rise to the challenge?
Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
[TBL] [Abstract][Full Text] [Related]
15. Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease.
Jeng MR; Adams-Graves P; Howard TA; Whorton MR; Li CS; Ware RE
Am J Hematol; 2003 Dec; 74(4):243-8. PubMed ID: 14635204
[TBL] [Abstract][Full Text] [Related]
16. Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.
Omondi NA; Ferguson SE; Majhail NS; Denzen EM; Buchanan GR; Haight AE; Labotka RJ; Rizzo JD; Murphy EA
J Pediatr Hematol Oncol; 2013 May; 35(4):289-98. PubMed ID: 23612380
[TBL] [Abstract][Full Text] [Related]
17. Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.
Odame I; Kulkarni R; Ohene-Frempong K
Am J Prev Med; 2011 Dec; 41(6 Suppl 4):S417-21. PubMed ID: 22099367
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.
Isa H; Adegoke S; Madu A; Hassan AA; Ohiaeri C; Chianumba R; Brown B; Okocha E; Ugwu N; Diaku-Akinwumi I; Adeyemo T; Kuliya-Gwarzo A; Dogara L; Lawal H; Tanko Y; Ladu A; Kangiwa U; Ekwem L; Oniyangi S; Wakama T; Umoru D; Olanrewaju O; Akinola N; Nnebe-Agumadu U; Asala S; Adekile A; Olaniyi J; Sangeda R; Sickle Africa Data Coordinating Center SADaCC ; Nnodu O
Blood Cells Mol Dis; 2020 Sep; 84():102438. PubMed ID: 32504882
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Plasmodium falciparum and non-P. falciparum infections in a highland district in Ghana, and the influence of HIV and sickle cell disease.
Owusu EDA; Brown CA; Grobusch MP; Mens P
Malar J; 2017 Apr; 16(1):167. PubMed ID: 28438159
[TBL] [Abstract][Full Text] [Related]
20. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
